Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
4.290
+0.220 (5.41%)
At close: Dec 5, 2025, 4:00 PM EST
4.340
+0.050 (1.17%)
After-hours: Dec 5, 2025, 7:57 PM EST
Ekso Bionics Holdings Market Cap
Ekso Bionics Holdings has a market cap or net worth of $14.55 million as of December 5, 2025. Its market cap has decreased by -6.70% in one year.
Market Cap
14.55M
Enterprise Value
16.79M
1-Year Change
-6.70%
Ranking
Category
Stock Price
$4.29
Market Cap Chart
Since January 17, 2014, Ekso Bionics Holdings's market cap has decreased from $15.60M to $14.55M, a decrease of -6.70%. That is a compound annual growth rate of -0.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 11.30M | -15.67% |
| Dec 31, 2024 | 13.40M | -62.36% |
| Dec 29, 2023 | 35.60M | 128.21% |
| Dec 30, 2022 | 15.60M | -53.57% |
| Dec 31, 2021 | 33.60M | -34.12% |
| Dec 31, 2020 | 51.00M | 74.06% |
| Dec 31, 2019 | 29.30M | -62.29% |
| Dec 31, 2018 | 77.70M | -39.11% |
| Dec 29, 2017 | 127.60M | 46.50% |
| Dec 30, 2016 | 87.10M | -16.57% |
| Dec 31, 2015 | 104.40M | -2.34% |
| Dec 31, 2014 | 106.90M | 585.26% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |